STEADY-STATE RELATIVE BIOAVAILABILITY AND PHARMACOKINETICS OF ORAL PROPRANOLOL IN BLACK AND WHITE NORTH AMERICANS

被引：13

作者：

SHAROKY, M

PERKAL, M

TURNER, R

LESKO, LJ

机构：

[1] UNIV MARYLAND,SCH PHARM,CLIN PHARMACOKINET LAB,20 N PINE ST,BALTIMORE,MD 21201

[2] PHARMAKINET LABS INC,BALTIMORE,MD

来源：

BIOPHARMACEUTICS & DRUG DISPOSITION | 1988年 / 9卷 / 05期

关键词：

D O I：

10.1002/bod.2510090503

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：447 / 456

页数：10

共 18 条

[1] BINDING OF BETA-ADRENOCEPTOR BLOCKING-DRUGS TO HUMAN-SERUM ALBUMIN, TO ALPHA-1-ACID GLYCOPROTEIN AND TO HUMAN-SERUM [J].

BELPAIRE, FM ;

BOGAERT, MG ;

ROSSENEU, M .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 22 (03) :253-256

[2]

CHIDSEY CA, 1974, CLIN RES, V22, pA100

[3]

EICHELBAUM M, 1977, CLIN PHARMACOKINET, V7, P1

[4]

GIBALDI M, 1975, DRUGS PHARM SCI PHAR

[5]

KORNHAUSER DM, 1978, CLIN PHARMACOL THER, V23, P165

[6] THE RELATIONSHIP BETWEEN DEBRISOQUINE OXIDATION PHENOTYPE AND THE PHARMACOKINETICS AND PHARMACODYNAMICS OF PROPRANOLOL [J].

LENNARD, MS ;

JACKSON, PR ;

FREESTONE, S ;

TUCKER, GT ;

RAMSAY, LE ;

WOODS, HF .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1984, 17 (06) :679-685

[7] POLYMORPHIC ABILITY TO METABOLIZE PROPRANOLOL ALTERS 4-HYDROXYPROPRANOLOL LEVELS BUT NOT BETA-BLOCKADE [J].

RAGHURAM, TC ;

KOSHAKJI, RP ;

WILKINSON, GR ;

WOOD, AJJ .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1984, 36 (01) :51-56

[8] COMPARATIVE PHARMACOKINETICS OF INTRAVENOUS PROPRANOLOL IN BLACK AND WHITE VOLUNTEERS [J].

VENTER, CP ;

JOUBERT, PH ;

STRYDOM, WJ .

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1985, 7 (02) :409-410

[9] ETHNIC-DIFFERENCES IN RESPONSE TO BETA-1-ADRENOCEPTOR BLOCKADE BY PROPRANOLOL [J].

VENTER, CP ;

JOUBERT, PH .

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1984, 6 (02) :361-364

[10]

VERVLOET E, 1977, CLIN PHARMACOL THER, V22, P853

← 1 2 →